RecruitingNot applicableNCT06373601

SPAGO: Sirolimus Paclitaxel Angiographic Gain Objective

Studying Cold agglutinin disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS
Principal Investigator
Antonio AC Colombo, MD
Fondazione Evidence ONLUS
Intervention
sirolimus-eluting balloon (Selution)(device)
Enrollment
140 target
Eligibility
18 years · All sexes
Timeline
2024 – 2027

Study locations (10)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06373601 on ClinicalTrials.gov

Other trials for Cold agglutinin disease

Additional recruiting or active studies for the same condition.

See all trials for Cold agglutinin disease →

← Back to all trials